To test if plasmin cleavage of human FasL could interfere with its killing function on activated T-cells in tumors, we tested three different mouse tumor cell lines (MC38, 4T1, ID8OVA) to generate human FasL-expressing tumors for syngeneic studies. The gene discussed is FASLG; the disease is neoplasm.